Ticker
APRECompany Name
APREA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 16.57M | $ 0 | $ -6.67M | $ 9.9M |
3/31/2025 | $ 19.32M | $ 0 | $ -10.85M | $ 8.46M |
12/31/2024 | $ 22.89M | $ 0 | $ -10.86M | $ 12.03M |
9/30/2024 | $ 26.29M | $ 0 | $ -4.66M | $ 21.63M |
6/30/2024 | $ 28.74M | $ 0 | $ -11.25M | $ 17.49M |
3/31/2024 | $ 32.41M | $ 0 | $ -426.99K | $ 31.98M |
12/31/2023 | $ 21.65M | $ 0 | $ 10.5M | $ 32.15M |
9/30/2023 | $ 25.39M | $ 0 | $ -10.26M | $ 15.13M |
6/30/2023 | $ 27.73M | $ 0 | $ -12.85M | $ 14.87M |
3/31/2023 | $ 31M | $ 0 | $ -17.34M | $ 13.66M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap + Debt - CashnEq
(=) EV
EV for APREA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 432.21M ] + Debt [ $ 377.08K ] - CashnEq [ $ 101.15M ]
(=) EV [ $ 331.44M ]
Minimum
Mar 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.32K |
---|---|
min | $ -1.69B |
max | $ 6.88B |
average | $ 1.25B |
median | $ 439.6M |
std | $ 1.67B |